SHIRE

pharmaceutical preparations for the treatment of central nervous system disorders, attention deficit/hyperactivity disorders, [ cardiovascular disorders, ] blood disorders, [ cancer, ] gastroenterological disorders, metabolic diseases, [ orthostatic hypotension, ] moderate to moderately severe pain [, and nausea ]

[ providing laboratory services in connection with pharmaceutical preparations for treatment of human illnesses developed by applicant or its affiliates ]